The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma: A multicenter retrospective study.
 
Yuan Cheng
No Relationships to Disclose
 
Junying Wang
No Relationships to Disclose
 
You Lu
No Relationships to Disclose
 
Yongxiang Xia
No Relationships to Disclose
 
Hui Zhao
No Relationships to Disclose
 
Qi Wang
No Relationships to Disclose
 
Xiaoli Zhu
No Relationships to Disclose
 
Qing-Quan Zu
No Relationships to Disclose
 
Huikai Li
No Relationships to Disclose
 
Zhong Chen
No Relationships to Disclose
 
Xiangcheng Li
No Relationships to Disclose
 
China Liver Cancer Study Group Young Investigators (CLEAP)
No Relationships to Disclose